At present, only a few GPD1L variants have been identified in patients affected by BrS, sudden infant death syndrome, diabetic dead-in-bed syndrome, cardiac conduction disorder, atrial fibrillation and early repolarisation syndrome, but only 6 of them have been functionally characterized [14, 27–35]. This evidence concerns the gene GPD1L and atrial fibrillation.